abstract |
The present invention relates generally to the inhibition of tumor growth. In particular, the invention concerns the prevention or treatment of tumor angiogenesis and the inhibition of tumor growth in tumors resistant to anti-VEGF treatment, using MEK inhibitors or G-CSF antagonists, either alone or in combination with a VEGF antagonist. |